Rebecca Bentley
Nurse Practitioner · Mount Vernon, TXNPI 1013472273
Payments from drug & device makers
Across 270 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$784
- AstraZeneca$475
- GSK$438
- Otsuka America Pharmaceutical, Inc.$265
- Axsome Therapeutics, Inc.$262
- Idorsia Pharmaceuticals US Inc$235
- plus $2K from 35 others
What the payments were for
- Food & beverage$4,83398%
- Education$200%
- Entertainment$200%
- Other$601%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 62 | $784 |
| AstraZeneca | 28 | $475 |
| GSK | 22 | $438 |
| Otsuka America Pharmaceutical, Inc. | 14 | $265 |
| Axsome Therapeutics, Inc. | 11 | $262 |
| Idorsia Pharmaceuticals US Inc | 10 | $235 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $234 |
| Corcept Therapeutics | 7 | $195 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $182 |
| Exact Sciences | 10 | $180 |
| Eisai Inc. | 4 | $163 |
| Lilly USA, LLC | 10 | $157 |
| Pfizer | 8 | $119 |
| Corium, LLC | 5 | $102 |
| Novo Nordisk | 4 | $98 |
| Bayer | 5 | $95 |
| Dexcom, Inc. | 5 | $95 |
| Amgen | 5 | $94 |
| Teva Pharmaceuticals USA, Inc. | 4 | $85 |
| Boehringer Ingelheim | 4 | $74 |
| Baxter Healthcare | 2 | $60 |
| Novartis | 3 | $56 |
| Lundbeck LLC | 2 | $54 |
| Indivior Inc. | 2 | $50 |
| Aprecia Pharmaceuticals, LLC | 2 | $37 |
| Mylan Specialty L.p. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 4 | $30 |
| Shield Therapeutics Inc | 2 | $30 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Insulet Corporation | 2 | $27 |
| Antares Pharma, Inc. | 1 | $26 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Nevro Corp. | 1 | $23 |
| Optos, Inc. | 1 | $20 |
| Orthofix Medical, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
| Merck | 1 | $12 |
| Organon | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,933 in reported general payments places this provider in the 90th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 68 | $68,583 |
| MounjaroTirzepatide | 50 | $52,526 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 39 | $24,546 |
| UbrelvyUbrogepant | 13 | $16,053 |
| LinzessLinaclotide | 22 | $14,218 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $4,959 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 55 | $3,144 |
| Levothyroxine Sodium | 127 | $1,182 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 55 | $1,101 |
| Celecoxib | 30 | $1,076 |
| Gabapentin | 95 | $990 |
| Pregabalin | 40 | $961 |
| Tramadol Hcl | 52 | $889 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 72 | $730 |
| Losartan Potassium | 66 | $727 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $98 | $68,58368 claims |
| Lilly USA, LLCMounjaro | $157 | $52,52650 claims |
| AbbVieUbrelvy, Linzess, Synthroid | $784 | $30,89851 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $475 | $29,50560 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Mount Vernon
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Monica WhiteLongview$118K
- Onna FeuchterSouthlake$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.